Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
18,830
+6,971
+59% +$669K 0.33% 85
2026
Q1
$1.23M Buy
11,859
+2,022
+21% +$229K 0.25% 105
2025
Q4
$992K Sell
9,837
-4,372
-31% -$475K 0.21% 116
2025
Q3
$1.75M Buy
14,209
+87
+0.6% +$10.8K 0.39% 74
2025
Q2
$1.7M Buy
14,122
+1,708
+14% +$228K 0.42% 74
2025
Q1
$1.83M Sell
12,414
-604
-5% -$92.2K 0.5% 59
2024
Q4
$2.11M Buy
13,018
+20
+0.2% +$3.27K 0.56% 55
2024
Q3
$2.12M Buy
12,998
+24
+0.2% +$3.56K 0.57% 53
2024
Q2
$1.77M Buy
12,974
+41
+0.3% +$5.69K 0.55% 57
2024
Q1
$1.98M Buy
12,933
+2
+0% +$299 0.64% 49
2023
Q4
$1.84M Buy
+12,931
New +$1.72M 0.67% 44
2023
Q1
Sell
-1,811
Closed -$254K 192
2022
Q4
$254K Buy
1,811
+83
+5% +$11.8K 0.12% 149
2022
Q3
$222K Buy
1,728
+19
+1% +$2.74K 0.12% 141
2022
Q2
$241K Buy
+1,709
New +$244K 0.11% 145

Other funds holding CLX

Lantz Financial's CLX Position: Q2 2026 in Review

Lantz Financial increased its Clorox (CLX) stake by 59% in Q2 2026, buying an estimated $669K and bringing the position to 18,830 shares worth $1.8M. The position accounts for 0.33% of the portfolio, ranked #85.

Lantz Financial first reported a position in CLX in Q2 2022 and has held it in 14 quarters since. The position peaked at $2.12M in Q3 2024. 197 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Lantz Financial held 18,830 shares of Clorox worth $1.8M as of Q2 2026.
  • Lantz Financial bought 6,971 Clorox shares in Q2 2026, an estimated $669K.
  • Clorox made up 0.33% of Lantz Financial's portfolio in Q2 2026, its #85 holding.
  • Lantz Financial first reported a position in Clorox in Q2 2022 and has held it in 14 quarters since.
  • Lantz Financial's Clorox position peaked at $2.12M in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.